Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma
- PMID: 16369985
- DOI: 10.1002/cncr.21616
Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma
Abstract
Background: Consultant gynecologic oncologists from the regional Comprehensive Cancer Center assisted community gynecologists in the surgical treatment of patients with ovarian carcinoma when they were invited. For this report, the authors evaluated the effects of primary surgery by a gynecologic oncologist on treatment outcome.
Methods: The hospital files from 680 patients with epithelial ovarian carcinoma who were diagnosed between 1994 and 1997 in the northern part of the Netherlands were abstracted. Treatment results were analyzed according to the operating physician's education by using survival curves and univariate and multivariate Cox regression analyses.
Results: Primary surgery was performed on 184 patients by gynecologic oncologists, and on 328 patients by general gynecologists. Gynecologic oncologists followed surgical guidelines more strictly compared with general gynecologists (patients with International Federation of Gynecology and Obstetrics [FIGO] Stage I-II disease, 55% vs. 33% [P=0.01]; patients with FIGO Stage III disease, 60% vs. 40% [P=0.003]) and more often removed all macroscopic tumor in patients with FIGO Stage III disease (24% vs. 12%; P=0.02). When patients were stratified according to FIGO stage, the 5-year overall survival rate was 86% versus 70% (P=0.03) for patients with Stage I-II disease and 21% versus 13% (P=0.02) for patients with Stage III-IV disease who underwent surgery by gynecologic oncologists and general gynecologists, respectively. The hazards ratio for patients who underwent surgery by gynecologic oncologists was 0.79 (95% confidence interval [95%CI], 0.61-1.03; adjusted for patient age, disease stage, type of hospital, and chemotherapy); when patients age 75 years and older were excluded, the hazards ratio fell to 0.71 (95% CI, 0.54-0.94) in multivariate analysis.
Conclusions: The surgical treatment of patients with ovarian carcinoma by gynecologic oncologists occurred more often according to surgical guidelines, tumor removal more often was complete, and survival was improved.
Copyright (c) 2005 American Cancer Society.
Similar articles
-
Influence of the gynecologic oncologist on the survival of ovarian cancer patients.Obstet Gynecol. 2007 Jun;109(6):1342-50. doi: 10.1097/01.AOG.0000265207.27755.28. Obstet Gynecol. 2007. PMID: 17540806
-
Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients.J Natl Cancer Inst. 2006 Feb 1;98(3):172-80. doi: 10.1093/jnci/djj019. J Natl Cancer Inst. 2006. PMID: 16449677
-
Prognostic factors for surgical outcome and survival in 447 women treated for advanced (FIGO-stages III-IV) epithelial ovarian carcinoma.Int J Oncol. 2007 Mar;30(3):727-34. Int J Oncol. 2007. PMID: 17273775
-
Who should operate on patients with ovarian cancer? An evidence-based review.Gynecol Oncol. 2005 Nov;99(2):447-61. doi: 10.1016/j.ygyno.2005.07.008. Epub 2005 Aug 29. Gynecol Oncol. 2005. PMID: 16126262 Review.
-
Breast surgery in stage IV breast cancer: impact of staging and patient selection on overall survival.Breast Cancer Res Treat. 2009 May;115(1):7-12. doi: 10.1007/s10549-008-0101-7. Epub 2008 Jun 26. Breast Cancer Res Treat. 2009. PMID: 18581232 Review.
Cited by
-
The educational game SonoQz improves diagnostic performance in ultrasound assessment of ovarian tumors.Acta Obstet Gynecol Scand. 2024 Oct;103(10):2053-2060. doi: 10.1111/aogs.14906. Epub 2024 Jul 31. Acta Obstet Gynecol Scand. 2024. PMID: 39082924 Free PMC article.
-
Utility of a Multi-Marker Panel with Ultrasound for Enhanced Classification of Adnexal Mass.Cancers (Basel). 2024 May 28;16(11):2048. doi: 10.3390/cancers16112048. Cancers (Basel). 2024. PMID: 38893167 Free PMC article.
-
ReClassification of Patients with Ambiguous CA125 for Optimised Pre-Surgical Triage.Diagnostics (Basel). 2024 Mar 22;14(7):671. doi: 10.3390/diagnostics14070671. Diagnostics (Basel). 2024. PMID: 38611584 Free PMC article.
-
Serum Lipidome Profiling Reveals a Distinct Signature of Ovarian Cancer in Korean Women.Cancer Epidemiol Biomarkers Prev. 2024 May 1;33(5):681-693. doi: 10.1158/1055-9965.EPI-23-1293. Cancer Epidemiol Biomarkers Prev. 2024. PMID: 38412029 Free PMC article.
-
Comparison of the ADNEX and ROMA risk prediction models for the diagnosis of ovarian cancer: a multicentre external validation in patients who underwent surgery.Br J Cancer. 2024 Apr;130(6):934-940. doi: 10.1038/s41416-024-02578-x. Epub 2024 Jan 19. Br J Cancer. 2024. PMID: 38243011
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
